These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not. Aas M; Melle I; Bettella F; Djurovic S; Le Hellard S; Bjella T; Ringen PA; Lagerberg TV; Smeland OB; Agartz I; Andreassen OA; Tesli M Psychol Med; 2018 Jan; 48(1):43-49. PubMed ID: 28967348 [TBL] [Abstract][Full Text] [Related]
5. Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder. Allardyce J; Leonenko G; Hamshere M; Pardiñas AF; Forty L; Knott S; Gordon-Smith K; Porteous DJ; Haywood C; Di Florio A; Jones L; McIntosh AM; Owen MJ; Holmans P; Walters JTR; Craddock N; Jones I; O'Donovan MC; Escott-Price V JAMA Psychiatry; 2018 Jan; 75(1):28-35. PubMed ID: 29167880 [TBL] [Abstract][Full Text] [Related]
6. Studying individual risk factors for self-harm in the UK Biobank: A polygenic scoring and Mendelian randomisation study. Lim KX; Rijsdijk F; Hagenaars SP; Socrates A; Choi SW; Coleman JRI; Glanville KP; Lewis CM; Pingault JB PLoS Med; 2020 Jun; 17(6):e1003137. PubMed ID: 32479557 [TBL] [Abstract][Full Text] [Related]
7. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Cross-Disorder Group of the Psychiatric Genomics Consortium Lancet; 2013 Apr; 381(9875):1371-1379. PubMed ID: 23453885 [TBL] [Abstract][Full Text] [Related]
11. Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders. Calafato MS; Thygesen JH; Ranlund S; Zartaloudi E; Cahn W; Crespo-Facorro B; Díez-Revuelta Á; Di Forti M; ; Hall MH; Iyegbe C; Jablensky A; Kahn R; Kalaydjieva L; Kravariti E; Lin K; McDonald C; McIntosh AM; McQuillin A; Picchioni M; Rujescu D; Shaikh M; Toulopoulou T; Os JV; Vassos E; Walshe M; Powell J; Lewis CM; Murray RM; Bramon E Br J Psychiatry; 2018 Sep; 213(3):535-541. PubMed ID: 30113282 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression. Holen B; Shadrin AA; Icick R; Filiz TT; Hindley G; Rødevand L; O'Connell KS; Hagen E; Frei O; Bahrami S; Cheng W; Parker N; Tesfaye M; Jahołkowski P; Karadag N; Dale AM; Djurovic S; Smeland OB; Andreassen OA Addict Biol; 2023 Jun; 28(6):e13282. PubMed ID: 37252880 [TBL] [Abstract][Full Text] [Related]
13. Post-partum psychosis and its association with bipolar disorder in the UK: a case-control study using polygenic risk scores. Di Florio A; Mei Kay Yang J; Crawford K; Bergink V; Leonenko G; Pardiñas AF; Escott-Price V; Gordon-Smith K; Owen MJ; Craddock N; Jones L; O'Donovan M; Jones I Lancet Psychiatry; 2021 Dec; 8(12):1045-1052. PubMed ID: 34715029 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci. Wiström ED; O'Connell KS; Karadag N; Bahrami S; Hindley GFL; Lin A; Cheng W; Steen NE; Shadrin A; Frei O; Djurovic S; Dale AM; Andreassen OA; Smeland OB Addiction; 2022 Mar; 117(3):600-610. PubMed ID: 34472679 [TBL] [Abstract][Full Text] [Related]